Skip to content
Sunday 13 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,650.44
+0.39%
DAX
25,568.56
+0.82%
CAC 40
8,179.77
+0.78%
STOXX 50
6,325.13
+0.90%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 22 September 2020 11:30 am  |  Updated:  Tuesday 22 September 2020 11:31 am

UK manufacturing orders stall for first time since April

By: Harry Robertson

Add as a preferred source on Google
UK manufacturing orders stall for first time since April
The CBI said UK factories are facing 'headwinds' from a resurgence of coronavirus

The UK’s manufacturing firms saw orders stagnate in September for the first time since April as companies faced “headwinds from a resurgence of the virus”, a new survey has shown.

However, manufacturing output volumes fell at a slower pace than in August, the latest CBI industrial trends survey said.

Anna Leach, CBI deputy chief economist, said: “It’s good to see that output volumes once again fell at a slower pace this month compared to August.”

Yet she said it “is disappointing to see the modest improvements in order books stall, with demand at a still weak level”.

Leach said that “manufacturing firms continue to battle against headwinds from a resurgence of the virus”. She called on the government to “step up its support”.

The monthly CBI survey showed that total order books deteriorated slightly compared to August. 

Orders down but output holds up

The overall balance of firms reporting a fall compared to those reporting a rise came in at minus 48 per cent. That was well below the long-run average of 14 per cent.

Yet output in the three months to September fell at a slower pace than in the three months to August, with a score of 20 per cent compared to 46 per cent a month earlier.

Tom Crotty, group director at Ineos and chair of the CBI manufacturing council, said: “Manufacturers have endured a very difficult summer and these weak activity figures are, therefore, not surprising. 

“Firms across the country are facing considerable uncertainty as the end of the job retention scheme.” He also said that “concerns about the potential for a no-deal Brexit have escalated as negotiations remain in stalemate.”

Crotty added: “It is also crucial that a deal is agreed with the EU, as it is essential to support the economic recovery across the UK.”

Read more

Manufacturing growth loses momentum as economic risks loom 

Manufacturing has suffered yet another downturn in activity over September.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Markets & Economics
  • News

Categories

  • Business
  • Economics

Trending Articles

  • Wetherspoon boss: ‘Not up to Burnham’ to choose who is on the high street 

  • Badger Beer maker Hall & Woodhouse doubles profit ahead of tie-up with James May

  • Four interest rate hikes loom despite surprise economic growth

  • Primark sales slip as owner dresses up retailer for demerger

  • Barclays faces legal scrutiny over role in £90m ‘Ponzi scheme within a Ponzi scheme’

More from Morning Wire

  • Manufacturing growth loses momentum as economic risks loom 

    Industrials
    Manufacturing has suffered yet another downturn in activity over September.
  • Perma-Pipe Secures More Than $67 Million in New Orders in the Second Quarter of 2026

    Business Wire
  • Manufacturers overcome gloomy economy as output surge continues

    Industrials
    Manufacturing sector faces mounting tribunal pressures amid economic uncertainty
  • Perma-Pipe and Welspun Announce Memorandum of Understanding to Establish Pipe Manufacturing and Coating Facilities in Jordan

    Business Wire
  • Astrazeneca explores $400bn megadeal with US rival 

    Markets
    AstraZeneca building exterior with logo, glass facade, UK flag, and wildflowers in foreground.
  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • ReNew Announces Results for the First Quarter for Fiscal Year 2027 (Q1 FY27), Ended June 30, 2026

    Business Wire
  • Vedanta Aluminium Reports Record Q1 FY27 Performance; Profit Surges 205%, EBITDA More Than Doubles

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook